BioSpace News Archive

To curb the misuse of unused medication and prescription opioid abuse, H-E-B is providing its pharmacy customers with a free, effective medication disposal solution.

After serving as General Counsel and Chief Operating Officer at Healthstat for the past fifteen years, the organization today announced that Warren Hutton has been named President in addition to his other roles.

China Biologic Products Holdings, Inc. announced that its board of directors has formed a special committee to review and evaluate the previously announced preliminary non-binding “going private” proposal that the Board received on September 18, 2019 from Beachhead Holdings Limited, CITIC Capital China Partners IV, L.P., PW Medtech Group Limited, Parfield International Ltd., HH Sum-XXII Holdings Limited and V-Sciences Investments Pte.

Soliton, Inc., (Nasdaq: SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center (“MD Anderson”), today announced that it has surpassed 75% of the required patients to be treated in its pivotal cellulite trial.

Company Aims to Educate Neck and Back Pain Sufferers About Effective Treatment Option

DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the online publication of a study in The Spine Journal [1] that summarizes the results of preclinical testing for Discogenic Cells, the active ingredient in IDCT, DiscGenics’ investigational cell therapy for disc degeneration.

Amplyx Pharmaceuticals, today announced that preclinical data for fosmanogepix (APX001) will be presented at the upcoming scientific conferences IDWeek 2019 in Washington D.C. from October 2-6, 2019, and the 9th Congress on Trends in Medical Mycology Meeting in Nice, France from October 11-14, 2019.

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of best-in-class bioproduction tools for cell and gene therapies, today announced a co-investment accelerator program with Casdin Capital, targeting early stage companies that are developing novel cell and gene therapy bioproduction tools.

CarboFix has announced today that the U.S. Food and Drug Administration (FDA) has cleared its CarboClear® Carbon Fiber Fenestrated Pedicle Screw System used in the treatment of patients with advanced stage spinal tumors.

Alliance Contract Pharma (ACP) announced today that the Company’s new $2 million Liquid Capsule filling line is fully operational.